MedTrace Logo

Exploration of Neuroimaging and Biochemical Prognostic Indicators for POCD

NCT02164669 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2014-06-16

No results posted yet for this study

Summary

Postoperative cognitive dysfunction (POCD) may lead to serious consequences. But the underlying mechanisms are still unclear. Blood Oxygen Level Dependent (BOLD) fMRI and biochemical indicators will be used to explore the underlying mechanisms and represent a promising precursory target for diagnosis and treatment of POCD.

Conditions

Sponsors & Collaborators

  • wangqiang

    lead OTHER

Principal Investigators

  • Qiang Wang, MD, PhD · Xijing Hospital

  • Zijun Gao, Dr. · Xijing Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2014-06-30
Completion
2014-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02164669 on ClinicalTrials.gov